Pfizer

NIVESTYM

View Prices
  1. Home
    2.  / 
  2. Q Code
    3.  / NIVESTYM – Q5110

Manufacturer:

Pfizer

Name:

NIVESTYM

HCPCS Code Descriptor:

Injection, filgrastim-aafi, biosimilar, (nivestym), 1 microgram

Category:

Q Code

HCPCS:

Q5110

NDC(s):

00069-0291-01, 00069-0291-10, 00069-0292-01, 00069-0292-10, 00069-0293-10, 00069-0294-10

Primary Type:

Oncology Biosimilar Colony Stimulating Factor

Generic Status:

Single-Source

Route of Administration:

Injection

About:

NIVESTYM is an Oncology Biosimilar Colony Stimulating Factor drug manufactured by Pfizer and administered via the Injection route of administration. The Q Code: Q5110 is aligned to the drug NIVESTYM.

Nivestym (pegfilgrastim) is an artificial protein that aids the production of white blood cells (neutrophils). Nivestym is manufactured by Pfizer and is biosimilar to the drug Neupogen (J1442). This drug has one HCPCS code, Q5110 that has been aligned to the medication since October 2018. Patient assistance programs for this medication can be found through Pfizer RxPathways.

View Prices

Access Pricing and More By Registering

Register Now

HCPCS Added Date:

10/1/18

HCPCS Effective Date:

10/1/18

HCPCS Short Description:

Nivestym

Billing and Coding Guide:

https://www.pfizeroncologytogether.com/files/NIVESTYM_Billing_and_Coding_Guide.pdf

Patient Assistance:

http://www.pfizerrxpathways.com/

NIVESTYM - Q5110